To characterize incidence rates and identify risk factors for admission and mortality in patients with endogenous endophthalmitis (EE) in the United States (US).
Patients with EE were identified using the Nationwide Emergency Department (NEDS) Database from 2006 to 2017 in this cross-sectional study. Subjects were required to have diagnoses of both endophthalmitis and septicaemia using contemporary International Classification of Diseases diagnosis codes. Incidence rates, mortality rates and demographics were evaluated. Risk factors for admission and mortality were identified using weighted logistic regression analysis.
A total of 6400 patients with EE were identified. Incidence increased from 0.10 (95% confidence interval [CI]: 0.07–0.12) per 100,000 in the US population in 2006 to 0.25 (95% CI: 0.21–0.30) in 2017 (p < 0.05). Most were female (55.4%), insured with Medicare (53.5%), were in the first income quartile earnings (29.3%) [bottom 25% income bracket], lived in the South (40.5%), and presented to metropolitan teaching hospitals (66.6%). Mortality increased from 8.6% (95% CI: 3.8–18.3%) in 2006 to 13.8% (95% CI: 9.7–19.2%) in 2017 (p = 0.94). Factors predicting admission included older age (odds ratio [OR] 32.59; [95% CI 2.95–359.78]) and intravenous drug use (OR 14.90 [95% CI: 1.67–133.16]). Factors associated with increased mortality included: human immunodeficiency virus infection/immune deficiencies (OR 2.58 [95% CI: 1.26–5.28]), heart failure (OR 2.12 [95% CI: 1.47–3.05]), and hepatic infections/cirrhosis (OR 1.89 [95% CI: 1.28–2.79]). Pneumonia and renal/urinary tract infections (UTI) were associated with both increased hospital admission [(pneumonia OR 9.64 (95% CI: 1.25–74.35, p = 0.030), renal/UTI OR 4.09 (95% CI: 1.77–9.48)] and mortality [(pneumonia OR 1.64 (95% CI: 1.17–2.29, p = 0.030), renal/UTI OR 1.87 (95% CI: 1.18–2.97)]. Patients with diabetes mellitus (DM) had decreased odds ratio for mortality (OR 0.49 [95% CI: 0.33–0.73]).
EE has increased in incidence throughout US. The two systemic factors that conferred both an increase in mortality and admission were pneumonia, and renal/UTI. Additional exploration of the potential protective association of DM with decreased mortality in this context is needed.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
The data that support the findings of this study are available from the Nationwide Emergency Department Sample (NEDS) but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of NEDS.
Novosad BD, Callegan MC. Severe bacterial endophthalmitis: towards improving clinical outcomes. Expert Rev Ophthalmol. 2010;5:689–98.
Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014;59:627–35.
Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986;31:81–101.
Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: A 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48:403–23.
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Executive summary: clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:409–17.
Breazzano MP, Day HR Jr, Bloch KC, Tanaka S, Cherney EF, Sternberg P Jr, et al. Utility of ophthalmologic screening for patients with Candida Bloodstream Infections: a systematic review. JAMA Ophthalmol. 2019;137:698–710.
Ratra D, Saurabh K, Das D, Nachiappan K, Nagpal A, Rishi E, et al. Endogenous endophthalmitis: A 10-Year Retrospective Study at a Tertiary Hospital in South India. Asia Pac. J Ophthalmol (Philos). 2015;4:286–92.
Hsieh M-C, Chen S-N, Cheng C-Y, Li K-H, Chuang C-C, Wu J-S, et al. Clinicomicrobiological profile, visual outcome and mortality of culture-proven endogenous endophthalmitis in Taiwan. Sci Rep. 2020;10:12481.
Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137:725–31.
Essman TF, Flynn HW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg lasers. 1997;28:185–94.
Sridhar J, Flynn HW Jr, Kuriyan AE, Miller D, Albini T. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3:60.
Budoff G, Thangamathesvaran L, Zarbin MA, Bhagat N. Bacterial endogenous endophthalmitis in bacteremic inpatients. Ophthalmol Retin. 2019;3:971–8.
Uppuluri A, Zarbin MA, Budoff G, Bhagat N. Risk factors for endogenous endophthalmitis in hospitalized patients with Candida Fungemia. Ophthalmol Retin. 2021;5:687–95.
NEDS Database Documentation. Healthcare Cost and Utilization Project (HCUP) [Internet]. Agency for Healthcare Research and Quality. 2020. Available from: www.hcup-us.ahrq.gov/db/nation/neds/nedsdbdocumentation.jsp.
Mir TA, Papudesu C, Fang W, Hinkle DM. Incidence of drug use–related endogenous endophthalmitis hospitalizations in the United States, 2003 to 2016. JAMA Ophthalmol. 2021;139:18–26.
Papudesu C, Mir T, Fang W, Thompson J, Hinkle DM. Trends in infantile endogenous endophthalmitis hospitalizations in the United States: an analysis from 2007 through 2014 using the national inpatient sample. Ophthalmol Retin. 2020;4:1109–17.
Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol. 2015;159:498–504.
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl J Med. 2003;348:1546–54.
Shiels MS, Almeida JS, García-Closas M, Albert PS, Freedman ND, Berrington, et al. Impact of population growth and aging on estimates of excess U.S. deaths during the COVID-19 pandemic, March to August 2020. Ann Intern Med. 2021;174:437–43.
Chee SP, Jap A. Endogenous endophthalmitis. Curr Opin Ophthalmol. 2001;12:464–70.
Pradipta IS, Sodik DC, Lestari K, Parwati I, Halimah E, Diantini A, et al. Antibiotic resistance in sepsis patients: evaluation and recommendation of antibiotic use. N. Am J Med Sci. 2013;5:344–52.
Kalil AC, Opal SM. Sepsis in the severely immunocompromised patient. Curr Infect Dis Rep. 2015;17:487.
Breazzano MP, Bond JB 3rd, Bearelly S, Kim DH, Donahue SP, Lum F, et al. American Academy of Ophthalmology recommendations on screening for endogenous candida endophthalmitis. Ophthalmology. 2022;129:73–6.
Channa R, Zafar SN, Canner JK, Haring RS, Schneider EB, Friedman DS. Epidemiology of eye-related emergency department visits. JAMA Ophthalmol. 2016;134:312–9.
Breazzano MP, Tooley AA, Godfrey KJ, Iacob CE, Yannuzzi NA, Flynn HW. Candida auris and endogenous panophthalmitis: clinical and histopathological features. Am J Ophthalmol Case Rep. 2020;19:100738.
Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of <em>Candida</em> bloodstream infection until positive blood culture results are obtained: a potential risk factor for Hospital Mortality. Antimicrobial Agents Chemother. 2005;49:3640–5.
Arfaras-Melainis A, Polyzogopoulou E, Triposkiadis F, Xanthopoulos A, Ikonomidis I, Mebazaa A, et al. Heart failure and sepsis: practical recommendations for the optimal management. Heart Fail Rev. 2020;25:183–94.
Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med. 2006;34:2576–82.
Bhavsar MM, Devarajan TV, Nembi PS, Ramakrishnan N, Mani AK. Metastatic endogenous endophthalmitis: a rare presentation with methicillin-resistant staphylococcus aureus prostatic abscess. Indian J Crit Care Med: peer-reviewed, Off Publ Indian Soc Crit Care Med. 2017;21:172–5.
Sadiq MA, Hassan M, Agarwal A, Sarwar S, Toufeeq S, Soliman MK, et al. Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect. 2015;5:32.
Weng T-H, Chang H-C, Chung C-H, Lin F-H, Tai M-C, Tsao C-H, et al. Epidemiology and mortality-related prognostic factors in endophthalmitis. Investigative Ophthalmol Vis Sci. 2018;59:2487–94.
Breazzano MP, Jonna G, Nathan NR, Nickols HH, Agarwal A. Endogenous Serratia marcescens panophthalmitis: a case series. Am J Ophthalmol Case Rep. 2019;16:100531.
Kuo G, Lu Y-A, Sun W-C, Chen C-Y, Kao H-K, Lin Y, et al. Epidemiology and outcomes of Endophthalmitis in chronic dialysis patients: a 13-year experience in a tertiary referral center in Taiwan. BMC Nephrol. 2017;18:270.
Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis: Off J Natl Kidney Found. 2002;39:549–55.
Rhee C, Jones TM, Hamad Y, Pande A, Varon J, O’Brien C, et al. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US Acute Care Hospitals. JAMA Netw Open. 2019;2:e187571–e.
Connell PP, O’Neill EC, Amirul Islam FM, Buttery R, McCombe M, Essex RH, et al. Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retin (Phila, Pa). 2010;30:1721–5.
Tirpack AR, Duker JS, Baumal CR. An outbreak of endogenous fungal endophthalmitis among intravenous drug abusers in New England. JAMA Ophthalmol. 2017;135:534–40.
Wang Z, Ren J, Wang G, Liu Q, Guo K, Li J. Association between diabetes mellitus and outcomes of patients with sepsis: a meta-analysis. Med Sci Monit: Int Med J Exp Clin Res. 2017;23:3546–55.
Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109:2698–704.
Annane D, Bellissant E, Cavaillon J-M. Septic shock. Lancet. 2005;365:63–78.
Kinasewitz GT, Yan SB, Basson B, Russell JA, Cariou A, Um SL, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care. 2004;8:R82.
Stegenga ME, Vincent J-L, Vail GM, Xie J, Haney DJ, Williams MD, et al. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med. 2010;38:539–45.
Krinsley JS, editor Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings; 2003: Elsevier.
Leonidou L, Mouzaki A, Michalaki M, DeLastic AL, Kyriazopoulou V, Bassaris HP, et al. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect. 2007;55:340–6.
Jiménez-Ibáñez EO, Castillejos-López M, Hernández A, Gorocica P, Alvarado-Vásquez N. High mortality associated with hyperglycemia, neutrophilia, and lymphopenia in critically ill patients. Tohoku J Exp Med. 2012;226:213–20.
Yu W-K, Li W-Q, Li N, Li J-S. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterology: WJG. 2003;9:1824.
Venot M, Weis L, Clec’h C, Darmon M, Allaouchiche B, Goldgran-Tolédano D, et al. Acute kidney injury in severe sepsis and septic shock in patients with and without diabetes mellitus: a multicenter study. PLoS ONE. 2015;10:e0127411.
Valerius N, Eff C, Hansen N, Karle H, Nerup J, Søeberg B, et al. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scandinavica. 1982;211:463–7.
Masuda M, Murakami T, Egawa H, Murata K. Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocin-induced diabetic rats. Diabetes. 1990;39:466–70.
Cui Y, Chen W, Chi J, Wang L. Comparison of transcriptome between type 2 diabetes mellitus and impaired fasting glucose. Med Sci Monit: Int Med J Exp Clin Res. 2016;22:4699.
This research was supported by unrestricted grants including Research to Prevent Blindness to the Wilmer Eye Institute (Baltimore, MD, USA) as well as from the VitreoRetinal Surgery Foundation in Edina, MN, USA (LT, MPB) and the Kogod Family (MPB).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Thangamathesvaran, L., Canner, J.K., Scott, A.W. et al. National emergency department trends for endogenous endophthalmitis: an increasing public health challenge. Eye (2022). https://doi.org/10.1038/s41433-022-02080-9